Jupiter Topco’s BioMarin Pharmaceuticals BMRN Stock Holding History

Jupiter Topco’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.2M	Buy	+755,192	New	+$41.4M	0.02%	466

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Jupiter Topco's BMRN Position: Q2 2026 in Review

Jupiter Topco opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2026: 755,192 shares worth $43.2M. The stake represents 0.02% of the portfolio and ranks #466 among its holdings.

526 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Jupiter Topco held 755,192 shares of BioMarin Pharmaceuticals worth $43.2M as of Q2 2026.
BioMarin Pharmaceuticals was a new Jupiter Topco position in Q2 2026.
BioMarin Pharmaceuticals made up 0.02% of Jupiter Topco's portfolio in Q2 2026, its #466 holding.
526 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.